James Armitage
Director/Board Member at TESARO INC
Net worth: 146 797 $ as of 2024-03-30
Profile
James O.
Armitage is currently the Director at Tesaro, Inc., the Independent Director at Cardiff Oncology, Inc., and a Professor-Internal Medicine at the University of Nebraska Medical Center.
Previously, he served as the Director at MGI PHARMA, Inc. from 2006 to 2008.
He also held positions as the President & Director of the American Society of Clinical Oncology, Inc. and as the President of the American Society for Blood & Marrow Transplantation.
Dr. Armitage obtained his undergraduate degree from the University of Nebraska and his doctorate from the University of Nebraska Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
0.06% | 2023-06-14 | 27,490 ( 0.06% ) | 146 797 $ | 2024-03-30 |
James Armitage active positions
| Companies | Position | Start |
|---|---|---|
| TESARO INC | Director/Board Member | 2013-05-08 |
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 2020-04-21 |
| University of Nebraska Medical Center | Corporate Officer/Principal | 1981-12-31 |
Former positions of James Armitage
| Companies | Position | End |
|---|---|---|
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Director/Board Member | 2008-01-28 |
| American Society for Blood & Marrow Transplantation | President | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | President | - |
Training of James Armitage
| University of Nebraska | Undergraduate Degree |
| University of Nebraska Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Private companies | 4 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
| American Society for Blood & Marrow Transplantation |
- Stock Market
- Insiders
- James Armitage
